Ferguson Wellman Capital Management, Inc / ABT
Ferguson Wellman Capital Management, Inc’s Abbott Laboratories Position
Does Ferguson Wellman Capital Management, Inc own Abbott Laboratories (ABT)? Yes — 176.6K shares worth $18M (+0.25% of its 13F portfolio) as of Q1 2026, down from 185.9K shares the prior filed quarter.
Position Value
$18M
Q1 2026
Shares
176.6K
% of Portfolio
+0.25%
Quarters Held
30
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 176.6K | $18M | +0.25% |
| Q4 2025 | 185.9K | $23M | +0.37% |
| Q3 2025 | 186.3K | $25M | +0.40% |
| Q2 2025 | 237.6K | $32M | +0.57% |
| Q1 2025 | 236.7K | $31M | +0.61% |
| Q4 2024 | 228.4K | $26M | +0.49% |
| Q3 2024 | 234.8K | $27M | +0.52% |
| Q2 2024 | 476.1K | $49M | +1.00% |
| Q1 2024 | 479.0K | $54M | +1.11% |
| Q4 2023 | 469.2K | $52M | +1.16% |
| Q3 2023 | 458.4K | $44M | +1.09% |
| Q2 2023 | 402.4K | $44M | +1.03% |
| Q1 2023 | 394.5K | $40M | +1.00% |
| Q4 2022 | 343.3K | $37,691 | +0.98% |
| Q3 2022 | 201.6K | $20M | +0.76% |
| Q2 2022 | 259.8K | $28M | +1.05% |
| Q1 2022 | 136.6K | $16M | +0.51% |
| Q4 2021 | 138.7K | $20M | +0.57% |
| Q3 2021 | 47.4K | $6M | +0.18% |
| Q2 2021 | 46.2K | $5M | +0.17% |
| Q1 2021 | 46.4K | $6M | +0.19% |
| Q4 2020 | 46.7K | $5M | +0.13% |
| Q3 2020 | 48.6K | $5M | +0.15% |
| Q2 2020 | 49.6K | $5M | +0.14% |
| Q1 2020 | 50.4K | $4M | +0.15% |
| Q4 2019 | 52.2K | $5M | +0.13% |
| Q3 2019 | 50.4K | $4M | +0.13% |
| Q2 2019 | 51.8K | $4M | +0.14% |
| Q1 2019 | 52.3K | $4M | +0.14% |
| Q4 2018 | 52.1K | $4M | +0.14% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ferguson Wellman Capital Management, Inc’s full portfolio or all institutional holders of ABT.